ProKidney Announces Q3 2025 Financial Outcomes and Key Developments
November 11, 2025 - 01:05
ProKidney has released its financial results for the third quarter of 2025, highlighting significant progress in its clinical studies and regulatory endeavors. The company recently showcased full results from the Phase 2 REGEN-007 study of rilparencel during a late-breaking clinical trial session at the American Society of Nephrology (ASN) Kidney Week 2025. This presentation underscores the promising developments in their research efforts.
As part of their ongoing commitment to advancing kidney disease treatment, ProKidney has successfully enrolled more than half of the patients needed for the Phase 3 REGEN-006 (PROACT 1) accelerated approval analysis, which focuses on the estimated glomerular filtration rate (eGFR) slope. The company anticipates topline results from this study to be available in the second quarter of 2027, marking a critical milestone in their clinical timeline.
Financially, ProKidney concluded the third quarter with a robust position, holding $272 million in cash, cash equivalents, and marketable securities. This financial strength positions the company well for future growth and innovation in the healthcare sector.
MORE NEWS
August 21, 2026 - 00:02
Broadcom Seeks More Than $60 Billion in Latest AI Debt DealBroadcom Inc. is negotiating with a consortium of lenders to secure upwards of $60 billion in new financing, a move aimed at bankrolling a major expansion of its artificial intelligence chip...
August 20, 2026 - 04:03
JPMorganChase to Present at the Barclays Global Financial Services ConferenceNEW YORK, August 19, 2026 - Doug Petno, who serves as Co-President of JPMorganChase and leads the firm`s Commercial & Investment Bank, is scheduled to appear at the Barclays Global Financial...
August 19, 2026 - 00:42
Sabalenka’s Coach Recalls Financial Sacrifices on Road to $50M CareerAryna Sabalenka has now banked more than fifty million dollars in career prize money, but the journey to that figure was far from glamorous. Her coach, Anton Dubrov, recently looked back on the...
August 18, 2026 - 04:03
Bending Spoons' Playbook: Buy Low—and HoldMost tech acquirers these days are looking for a quick flip. They buy a struggling app, cut costs, squeeze out whatever revenue they can, and then sell the shell to the next buyer within a year or...